HI
VNDA icon

HBK Investments’s Vanda Pharmaceuticals VNDA Stock Holding History

HBK Investments’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-148,217
Closed -$2.73M – 1053
2019
Q1 		$2.73M Sell
148,217
-64,782
-30% -$1.48M 0.03% 439
2018
Q4 		$5.57M Buy
212,999
+5,703
+3% +$134K 0.06% 257
2018
Q3 		$4.76M Buy
207,296
+15,972
+8% +$326K 0.04% 302
2018
Q2 		$3.65M Buy
191,324
+89,024
+87% +$1.49M 0.02% 336
2018
Q1 		$1.72M Buy
102,300
+56,900
+125% +$952K 0.01% 488
2017
Q4 		$690K Sell
45,400
-20,200
-31% -$300K 0.01% 683
2017
Q3 		$1.17M Sell
65,600
-8,900
-12% -$149K 0.01% 586
2017
Q2 		$1.21M Buy
+74,500
New +$1.07M 0.01% 524

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

HBK Investments's VNDA Position: Q2 2019 in Review

HBK Investments sold out of Vanda Pharmaceuticals (VNDA) in Q2 2019, closing a stake of 148,217 shares — an estimated $2.73M sold.

HBK Investments first reported a position in VNDA in Q2 2017 and held it in 8 quarters. The position peaked at $5.57M in Q4 2018. 164 funds tracked by Wall St. Rank hold VNDA as of Q2 2019.

  • HBK Investments reported no remaining Vanda Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • HBK Investments sold 148,217 Vanda Pharmaceuticals shares in Q2 2019, an estimated $2.73M.
  • HBK Investments first reported a position in Vanda Pharmaceuticals in Q2 2017 and held it in 8 quarters.
  • HBK Investments's Vanda Pharmaceuticals position peaked at $5.57M in Q4 2018.
  • 164 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2019.

Based on HBK Investments's 13F filing for Q2 2019, filed 14 Aug 2019.